The REVEAL-SCAN study

The “Risk Evaluation and Education for Alzheimer’s Disease – the Study of Communicating Amyloid Neuroimaging” study (REVEAL-SCAN for short) is
Read More

The Generation Study

The Generation Study is a phase II/III clinical trial to test whether the drug CAD106 prevents Alzheimer’s disease. Cognitively normal
Read More

The Biogen Study

The Biogen study is a Phase II clinical research study of the drug aducanumab for individuals age 50-85 with early
Read More

The A4 Study

The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s study (A4 for short), is a clinical research study for older individuals who may
Read More

The ASL-PET Study

The purpose of the ASL-PET study is to determine the value of a special MRI scan that measures cerebral blood
Read More